Skip to main content
Erschienen in: Inflammation 1/2012

01.02.2012

Cholesterol 27-Hydroxylase but Not Apolipoprotein apoE Contributes to A2A Adenosine Receptor Stimulated Reverse Cholesterol Transport

verfasst von: Taiese Crystal Bingham, Saj Parathath, Heather Tian, Allison Reiss, Edwin Chan, Edward A. Fisher, Bruce N. Cronstein

Erschienen in: Inflammation | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Movement of free cholesterol between the cellular compartment and acceptor is governed by cholesterol gradients that are determined by several enzymes and reverse cholesterol transport proteins. We have previously demonstrated that adenosine A2A receptors inhibit foam cell formation and stimulate production of cholesterol 27-hydroxylase (CYP27A1), an enzyme involved in the conversion of cholesterol to oxysterols. We therefore asked whether the effect of adenosine A2A receptors on foam cell formation in vitro is mediated by CYP27A1 or apoE, a carrier for cholesterol in the serum. We found that specific lentiviral siRNA infection markedly reduced apoE or 27-hydroxylase mRNA in THP-1 cells. Despite diminished apoE expression (p < 0.0002, interferon-gamma (IFNγ) CGS vs. IFNγ alone, n = 4), CGS-21680, an adenosine A2A receptor agonist, inhibits foam cell formation. In contrast, CGS-21680 had no effect on reducing foam cell formation in CYP27A1 KD cells (4 ± 2%; p < 0.5113, inhibition vs. IFNγ alone, n = 4). Previously, we reported the A2A agonist CGS-21680 increases apoAI-mediated cholesterol efflux nearly twofold in wild-type macrophages. Adenosine receptor activation had no effect on cholesterol efflux in CYP27A1 KD cells but reduced efflux in apoE KD cells. These results demonstrate that adenosine A2A receptor occupancy diminishes foam cell formation by increasing expression and function of CYP27A1.
Literatur
1.
Zurück zum Zitat Bingham, T.C., E.A. Fisher, S. Parathath, A.B. Reiss, E.S. Chan, and B.N. Cronstein. 2010. A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux. Journal of Leukocyte Biology 87(4): 683–690. doi:jlb.070951310.1189/jlb.0709513.PubMedCrossRef Bingham, T.C., E.A. Fisher, S. Parathath, A.B. Reiss, E.S. Chan, and B.N. Cronstein. 2010. A2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux. Journal of Leukocyte Biology 87(4): 683–690. doi:jlb.​070951310.​1189/​jlb.​0709513.PubMedCrossRef
2.
Zurück zum Zitat Reiss, A.B., D.W. Wan, K. Anwar, J.T. Merrill, P.A. Wirkowski, N. Shah, B.N. Cronstein, E.S. Chan, and S.E. Carsons. 2009. Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: Linking autoimmunity and atherosclerosis. Experimental Biology and Medicine (Maywood) 234(3): 354–360. doi:0806-BC-19410.3181/0806-BC-194.CrossRef Reiss, A.B., D.W. Wan, K. Anwar, J.T. Merrill, P.A. Wirkowski, N. Shah, B.N. Cronstein, E.S. Chan, and S.E. Carsons. 2009. Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: Linking autoimmunity and atherosclerosis. Experimental Biology and Medicine (Maywood) 234(3): 354–360. doi:0806-BC-19410.​3181/​0806-BC-194.CrossRef
3.
Zurück zum Zitat Reiss, A.B., M.M. Rahman, E.S. Chan, M.C. Montesinos, N.W. Awadallah, and B.N. Cronstein. 2004. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. Journal of Leukocyte Biology 76(3): 727–734.PubMedCrossRef Reiss, A.B., M.M. Rahman, E.S. Chan, M.C. Montesinos, N.W. Awadallah, and B.N. Cronstein. 2004. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. Journal of Leukocyte Biology 76(3): 727–734.PubMedCrossRef
4.
Zurück zum Zitat Reiss, A.B., C.A. Patel, M.M. Rahman, E.S. Chan, K. Hasneen, M.C. Montesinos, J.D. Trachman, and B.N. Cronstein. 2004. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Medical Science Monitor 10(11): BR420–BR425. doi:6060.PubMed Reiss, A.B., C.A. Patel, M.M. Rahman, E.S. Chan, K. Hasneen, M.C. Montesinos, J.D. Trachman, and B.N. Cronstein. 2004. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Medical Science Monitor 10(11): BR420–BR425. doi:6060.PubMed
5.
Zurück zum Zitat Reiss, A.B., N.W. Awadallah, S. Malhotra, M.C. Montesinos, E.S. Chan, N.B. Javitt, and B.N. Cronstein. 2001. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. Journal of Lipid Research 42(11): 1913–1922.PubMed Reiss, A.B., N.W. Awadallah, S. Malhotra, M.C. Montesinos, E.S. Chan, N.B. Javitt, and B.N. Cronstein. 2001. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. Journal of Lipid Research 42(11): 1913–1922.PubMed
7.
Zurück zum Zitat Westman, J., B. Kallin, I. Bjorkhem, J. Nilsson, and U. Diczfalusy. 1998. Sterol 27-hydroxylase- and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages: evidence for an inverse relation between the two mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology 18(4): 554–561.PubMedCrossRef Westman, J., B. Kallin, I. Bjorkhem, J. Nilsson, and U. Diczfalusy. 1998. Sterol 27-hydroxylase- and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages: evidence for an inverse relation between the two mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology 18(4): 554–561.PubMedCrossRef
8.
Zurück zum Zitat Norlin, M., and K. Wikvall. 2007. Enzymes in the conversion of cholesterol into bile acids. Current Molecular Medicine 7(2): 199–218.PubMedCrossRef Norlin, M., and K. Wikvall. 2007. Enzymes in the conversion of cholesterol into bile acids. Current Molecular Medicine 7(2): 199–218.PubMedCrossRef
9.
Zurück zum Zitat Davignon, J., J.S. Cohn, L. Mabile, and L. Bernier. 1999. Apolipoprotein E and atherosclerosis: Insight from animal to human studies. Clinica Chimica Acta 286(1–2): 115–143.CrossRef Davignon, J., J.S. Cohn, L. Mabile, and L. Bernier. 1999. Apolipoprotein E and atherosclerosis: Insight from animal to human studies. Clinica Chimica Acta 286(1–2): 115–143.CrossRef
11.
Zurück zum Zitat Chao, W.T., S.H. Tsai, Y.C. Lin, W.W. Lin, and V.C. Yang. 2005. Cellular localization and interaction of ABCA1 and caveolin-1 in aortic endothelial cells after HDL incubation. Biochemical and Biophysical Research Communications 332(3): 743–749.PubMedCrossRef Chao, W.T., S.H. Tsai, Y.C. Lin, W.W. Lin, and V.C. Yang. 2005. Cellular localization and interaction of ABCA1 and caveolin-1 in aortic endothelial cells after HDL incubation. Biochemical and Biophysical Research Communications 332(3): 743–749.PubMedCrossRef
12.
Zurück zum Zitat Hara, S., T. Shike, N. Takasu, and T. Mizui. 1997. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 17(7): 1258–1266.PubMedCrossRef Hara, S., T. Shike, N. Takasu, and T. Mizui. 1997. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 17(7): 1258–1266.PubMedCrossRef
13.
Zurück zum Zitat Reiss, A.B., S.E. Carsons, K. Anwar, S. Rao, S.D. Edelman, H. Zhang, P. Fernandez, B.N. Cronstein, and E.S. Chan. 2008. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis and Rheumatism 58(12): 3675–3683.PubMedCrossRef Reiss, A.B., S.E. Carsons, K. Anwar, S. Rao, S.D. Edelman, H. Zhang, P. Fernandez, B.N. Cronstein, and E.S. Chan. 2008. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis and Rheumatism 58(12): 3675–3683.PubMedCrossRef
14.
Zurück zum Zitat Fu, X., J.G. Menke, Y. Chen, G. Zhou, K.L. MacNaul, S.D. Wright, C.P. Sparrow, and E.G. Lund. 2001. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. The Journal of Biological Chemistry 276(42): 38378–38387.PubMedCrossRef Fu, X., J.G. Menke, Y. Chen, G. Zhou, K.L. MacNaul, S.D. Wright, C.P. Sparrow, and E.G. Lund. 2001. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. The Journal of Biological Chemistry 276(42): 38378–38387.PubMedCrossRef
15.
Zurück zum Zitat Heeren, J., U. Beisiegel, and T. Grewal. 2006. Apolipoprotein E recycling: Implications for dyslipidemia and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 26(3): 442–448.PubMedCrossRef Heeren, J., U. Beisiegel, and T. Grewal. 2006. Apolipoprotein E recycling: Implications for dyslipidemia and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 26(3): 442–448.PubMedCrossRef
16.
Zurück zum Zitat Hatters, D.M., C.A. Peters-Libeu, and K.H. Weisgraber. 2006. Apolipoprotein E structure: Insights into function. Trends in Biochemical Sciences 31(8): 445–454.PubMedCrossRef Hatters, D.M., C.A. Peters-Libeu, and K.H. Weisgraber. 2006. Apolipoprotein E structure: Insights into function. Trends in Biochemical Sciences 31(8): 445–454.PubMedCrossRef
Metadaten
Titel
Cholesterol 27-Hydroxylase but Not Apolipoprotein apoE Contributes to A2A Adenosine Receptor Stimulated Reverse Cholesterol Transport
verfasst von
Taiese Crystal Bingham
Saj Parathath
Heather Tian
Allison Reiss
Edwin Chan
Edward A. Fisher
Bruce N. Cronstein
Publikationsdatum
01.02.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9288-y

Weitere Artikel der Ausgabe 1/2012

Inflammation 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.